Mesoblast: Rapid Improvement And Remission In Patients With Refractory Ulcerative Colitis And Crohn's Colitis After Direct Injection Of Remestemcel-L By Colonoscopy

Press/Media

Period20 Feb 2022

Media coverage

1

Media coverage

  • TitleMesoblast: Rapid Improvement And Remission In Patients With Refractory Ulcerative Colitis And Crohn's Colitis After Direct Injection Of Remestemcel-L By Colonoscopy
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date20/02/22
    PersonsEric Rose